3 terminated. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
| Phase 1 | 1 | Terminated 1 |
Follow Urinary Calculi: new trials by email Literature Review of Urinary Calculi trials Research Report on Urinary Calculi
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate Lumasiran in Adults With Recurrent Calcium Oxalate Kidney Stone Disease and Elevated Urinary Oxalate Levels Lumasiran, Placebo - Recurrent Calcium Oxalate Kidney Stone Disease, Elevated Urinary Oxalate Levels | Phase 2 | Terminated | Alnylam Pharmaceuticals | 2 | 2022-01-27 | 2024-05-22 |
| Safety, Tolerability, and Pharmacodynamics of NOV-001 in Adult Subjects NOV-001, NB1000S, NB2000P - Healthy Volunteers, Enteric Hyperoxaluria | Phase 1 / Phase 2 | Terminated | Novome Biotechnologies Inc | 153 | 2021-06-02 | 2023-05-17 |
| Efficacy and Safety of Using MPC-5971 in Subjects Undergoing Shock Wave Lithotripsy placebo, MPC-5971 - Nephrolithiasis | Phase 2 | Terminated | Mission Pharmacal | 135 | 2010-04-01 | 2019-03-07 |
Kidney Calculi (3) · Hyperoxaluria (1) · Nephrolithiasis (1) · Urolithiasis (1)
Calculi (3) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Kidney Diseases (3) · Male Urogenital Diseases (3) · Pathological Conditions, Anatomical (3) · Pathological Conditions, Signs and Symptoms (3) · Urogenital Diseases (3) · Urologic Diseases (3) · Nephrolithiasis (2) · Urolithiasis (2)
lumasiran (1)
Alnylam Pharmaceuticals (1) · Mission Pharmacal (1) · Novome Biotechnologies Inc (1)
United States (3) · Belgium (1) · Canada (1) · Italy (1) · Spain (1) · Switzerland (1) · United Kingdom (1)